276 related articles for article (PubMed ID: 34663095)
1. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
[TBL] [Abstract][Full Text] [Related]
2. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
[TBL] [Abstract][Full Text] [Related]
3. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
[TBL] [Abstract][Full Text] [Related]
4. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
5. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis.
Zozaya M; Ferris MJ; Siren JD; Lillis R; Myers L; Nsuami MJ; Eren AM; Brown J; Taylor CM; Martin DH
Microbiome; 2016 Apr; 4():16. PubMed ID: 27090518
[TBL] [Abstract][Full Text] [Related]
6. Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda.
Liu CM; Hungate BA; Tobian AA; Ravel J; Prodger JL; Serwadda D; Kigozi G; Galiwango RM; Nalugoda F; Keim P; Wawer MJ; Price LB; Gray RH
mBio; 2015 Jun; 6(3):e00589. PubMed ID: 26081632
[TBL] [Abstract][Full Text] [Related]
7. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.
Ratten LK; Plummer EL; Murray GL; Danielewski J; Fairley CK; Garland SM; Hocking JS; Tachedjian G; Chow E; Bradshaw CS; Vodstrcil LA
BJOG; 2021 Mar; 128(4):756-767. PubMed ID: 33480468
[TBL] [Abstract][Full Text] [Related]
8. Treatment considerations for bacterial vaginosis and the risk of recurrence.
Chen JY; Tian H; Beigi RH
J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
[TBL] [Abstract][Full Text] [Related]
9. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment.
Vodstrcil LA; Muzny CA; Plummer EL; Sobel JD; Bradshaw CS
BMC Med; 2021 Sep; 19(1):194. PubMed ID: 34470644
[TBL] [Abstract][Full Text] [Related]
10. The vaginal microbiota in the course of bacterial vaginosis treatment.
Zwittink RD; van den Munckhof EHA; Leverstein-van Hall MA; Boers K; Molijn A; Knetsch CW; Kuijper EJ
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):651-656. PubMed ID: 33029765
[TBL] [Abstract][Full Text] [Related]
11. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
12. Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis.
Plummer EL; Sfameni AM; Vodstrcil LA; Danielewski JA; Murray GL; Fehler G; Fairley CK; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
J Infect Dis; 2023 Aug; 228(5):646-656. PubMed ID: 37427495
[TBL] [Abstract][Full Text] [Related]
13. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
14. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial.
Colli E; Landoni M; Parazzini F
Genitourin Med; 1997 Aug; 73(4):267-70. PubMed ID: 9389947
[TBL] [Abstract][Full Text] [Related]
15. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment for the sexual partners of women with bacterial vaginosis.
Amaya-Guio J; Viveros-Carreño DA; Sierra-Barrios EM; Martinez-Velasquez MY; Grillo-Ardila CF
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011701. PubMed ID: 27696372
[TBL] [Abstract][Full Text] [Related]
17. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Women and Their Male Sex Partners Predict Bacterial Vaginosis Among a Prospective Cohort of Kenyan Women With Nonoptimal Vaginal Microbiota.
Mehta SD; Agingu W; Nordgren RK; Green SJ; Bhaumik DK; Bailey RC; Otieno F
Sex Transm Dis; 2020 Dec; 47(12):840-850. PubMed ID: 32773610
[TBL] [Abstract][Full Text] [Related]
19. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
